Performance of a Rapid and Simple HIV Testing Algorithm in a Multicenter Phase III Microbicide Clinical Trial
- 13 July 2011
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 18 (9), 1480-1485
- https://doi.org/10.1128/cvi.05069-11
Abstract
A multitest sequential algorithm based on rapid and simple (R/S) assays was applied for the diagnosis of HIV infection among participants in a phase 3 microbicide effectiveness trial. HIV testing was performed on finger-prick blood samples obtained from patients after their enrollment in the trial. The specimens were tested in a serial procedure using three different rapid tests (Determine HIV-1/2 [Abbott], SD Bioline HIV-1/2 3.0 [Standard Diagnostics], and Uni-Gold HIV [Trinity Biotech]). In the event of discordant results between the Determine HIV-1/2 and SD Bioline HIV-1/2 3.0 tests, the third assay (Uni-Gold HIV) determined the final outcome. When the final outcome was positive, a second specimen was collected and tested with the same algorithm, only if a positive result was obtained with this sample the participant was informed of her positive serostatus. A total of 5,734 postenrollment specimens obtained from 1,398 women were tested. Forty-six women tested positive according to the testing algorithm performed on the first collected specimen. Confirmatory testing results obtained at the ITM confirmed that 42 women were truly infected. Two of four initial false positives tested negative upon analysis of a second blood specimen. The other two tested false positive twice using specimens collected the same day. A high percentage of specimens reactive with the Determine HIV-1/2 assay was only observed at the study site in Kampala. This result did not appear to be associated with pregnancy or malaria infection. We conclude that HIV testing algorithms, including only R/S assays, are suitable for use in clinical trials, provided that adequate quality assurance procedures are in place.This publication has 21 references indexed in Scilit:
- Obtaining Valid Laboratory Data in Clinical Trials Conducted in Resource Diverse Settings: Lessons Learned from a Microbicide Phase III Clinical TrialPLOS ONE, 2010
- Low Specificities of HIV Diagnostic Tests Caused by Trypanosoma brucei gambiense Sleeping SicknessJournal of Clinical Microbiology, 2010
- Association of Schistosomiasis with False-Positive HIV Test Results in an African Adolescent PopulationJournal of Clinical Microbiology, 2010
- Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversionJournal of Virological Methods, 2010
- Suitability of Simple Human Immunodeficiency Virus Rapid Tests in Clinical Trials in Community-Based Clinic SettingsJournal of Clinical Microbiology, 2009
- Does POCT reduce the risk of error in laboratory testing?Clinica Chimica Acta; International Journal of Clinical Chemistry, 2009
- The Evaluation of a Rapid In Situ HIV Confirmation Test in a Programme with a High Failure Rate of the WHO HIV Two-Test Diagnostic AlgorithmPLOS ONE, 2009
- Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV TransmissionNew England Journal of Medicine, 2008
- Large-Scale Human Immunodeficiency Virus Rapid Test Evaluation in a Low-Prevalence Ugandan Blood Bank PopulationJournal of Clinical Microbiology, 2007
- Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trialThe Lancet, 2007